Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

BDTXBlack Diamond Therapeutics, Inc.

Nasdaq · CIK 0001701541
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts246

Identity from submissions API

NameBlack Diamond Therapeutics, Inc.
CIK0001701541
TickersBDTX
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN814254660
LEI—
Fiscal year end1231
State of incorporation—
Phone617-417-5868
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Aset Therapeutics, Inc. (2017-03-28T04:00:00.000Z → 2018-01-04T05:00:00.000Z)
Business address
245 FIRST STREET, 18TH FLOOR
CAMBRIDGE
MA
02142
MA
Mailing address
245 FIRST STREET, 18TH FLOOR
CAMBRIDGE
MA
02142
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

487 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-10 10-Q 10-Q 0001701541-26-000032 001-39200 261537796 34 5344080 1 1
2026-11-10 8-K 8-K 2.02,9.01 0001701541-26-000030 001-39200 261537781 34 241646 1 1
2026-09-21 4 4 0001193125-26-396868 6418
2026-09-21 4 xslF345X06/form4-09212026_090921.xml 0002018686-26-000014 5423
2026-08-05 10-Q 10-Q 0001701541-26-000025 001-39200 261243316 34 5298818 1 1
2026-08-05 8-K 8-K 2.02,9.01 0001701541-26-000023 001-39200 261243238 34 232233 1 1
2026-07-27 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-002206 005-91312 261206100 34 10943
2026-07-08 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001897612-26-000526 005-91312 261161388 34 7718
2026-06-29 4 4 0001193125-26-288598 5443
2026-06-29 4 xslF345X06/form4-06292026_080654.xml 0001682019-26-000002 5758
2026-06-29 4 xslF345X06/form4-06292026_080611.xml 0001556064-26-000002 5754
2026-06-29 4 xslF345X06/form4-06292026_080611.xml 0002018686-26-000012 5773
2026-06-29 4 xslF345X06/form4-06292026_080659.xml 0001456849-26-000002 5708
2026-06-29 4 xslF345X06/form4-06292026_080653.xml 0002018966-26-000007 5778
2026-06-29 8-K FORM 8-K 5.07 0001104659-26-078847 001-39200 261136009 34 205700 1 1
2026-06-22 4 4 0001193125-26-277553 6413
2026-06-22 4 xslF345X06/form4-06222026_080600.xml 0002018686-26-000008 5418
2026-05-21 8-K FORM 8-K 7.01,8.01,9.01 0001104659-26-065254 001-39200 261009935 34 311591 1 1
2026-05-07 10-Q 10-Q 0001701541-26-000017 001-39200 26950859 34 4784443 1 1
2026-05-07 8-K 8-K 2.02,9.01 0001701541-26-000015 001-39200 26950854 34 211218 1 1
2026-04-29 ARS ARS 0001104659-26-051509 001-39200 26916126 34 2331480
2026-04-29 DEFA14A DEFA14A 0001104659-26-051492 001-39200 26915931 34 7326617
2026-04-29 DEF 14A DEF 14A 0001104659-26-051474 001-39200 26915733 34 2794077 1 1
2026-03-20 4 4 0001193125-26-117938 6341
2026-03-20 4 xslF345X06/form4-03202026_090300.xml 0002018686-26-000002 5347
2026-03-16 S-8 FORM S-8 0001104659-26-028461 333-294347 26756815 33 195693 1 1
2026-03-16 10-K 10-K 0001701541-26-000009 001-39200 26756534 34 8496502 1 1
2026-03-16 8-K 8-K 2.02,9.01 0001701541-26-000008 001-39200 26756514 34 226588 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-26-001085 005-91312 26641149 34 10919
2026-01-23 4 xslF345X05/form4-01232026_040111.xml 0001895913-26-000002 5732
2026-01-23 4 xslF345X05/form4-01232026_040109.xml 0001637054-26-000002 5693
2026-01-23 4 xslF345X05/form4-01232026_040106.xml 0001880385-26-000002 5656
2026-01-23 4 xslF345X05/form4-01232026_040104.xml 0001686295-26-000002 5643
2026-01-23 4 xslF345X05/form4-01232026_040101.xml 0001706847-26-000002 5655
2025-12-15 4 4 0001193125-25-319303 6279
2025-12-15 4 xslF345X05/form4-12152025_091210.xml 0002018686-25-000007 5285
2025-12-03 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003511 333-291518 251548157 33 1834
2025-12-03 8-K FORM 8-K 2.02,7.01,8.01,9.01 0001104659-25-117975 001-39200 251545048 34 5608283 1 1
2025-12-01 CORRESP filename1.htm 0001104659-25-117310 6984
2025-11-13 S-3 S-3 0001104659-25-111490 333-291518 251479807 33 1790366 1 1
2025-11-06 10-Q 10-Q 0001701541-25-000039 001-39200 251456122 34 5357031 1 1
2025-11-06 8-K 8-K 2.02,9.01 0001701541-25-000038 001-39200 251456067 34 228535 1 1
2025-09-22 4 4 0001193125-25-211678 6309
2025-09-22 4 xslF345X05/form4-09222025_090933.xml 0002018686-25-000004 5314
2025-08-07 10-Q 10-Q 0001701541-25-000030 001-39200 251191522 34 5338485 1 1
2025-08-07 8-K 8-K 2.02,9.01 0001701541-25-000029 001-39200 251191506 34 229871 1 1
2025-06-20 4 4 0000950170-25-088527 6304
2025-06-20 4 xslF345X05/form4-06202025_080647.xml 0001415889-25-017821 5309
2025-06-12 4 4 0000950170-25-085676 35211
2025-06-12 4 xslF345X05/form4-06122025_100637.xml 0001415889-25-017058 5665
2025-06-12 4 xslF345X05/form4-06122025_100652.xml 0001415889-25-017056 5664
2025-06-12 4 xslF345X05/form4-06122025_100629.xml 0001415889-25-017053 5670
2025-06-12 4 xslF345X05/form4-06122025_100609.xml 0001415889-25-017050 5600
2025-06-12 4 xslF345X05/form4-06122025_100615.xml 0001415889-25-017048 5650
2025-06-12 8-K FORM 8-K 5.07 0001104659-25-058893 001-39200 251042905 34 201324 1 1
2025-05-12 10-Q 10-Q 0001701541-25-000022 001-39200 25934839 34 5488634 1 1
2025-05-12 8-K 8-K 2.02,9.01 0001701541-25-000021 001-39200 25934774 34 228197 1 1
2025-04-29 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-001839 005-91312 25882768 34 11118
2025-04-18 ARS ARS 0001104659-25-036343 001-39200 25850503 34 1511867
2025-04-18 DEFA14A DEFA14A 0001104659-25-036341 001-39200 25850469 34 353698
2025-04-18 DEF 14A DEF 14A 0001104659-25-036339 001-39200 25850450 34 2045283 1 1
2025-03-21 4 4 0000950170-25-043221 6311
2025-03-21 4 xslF345X05/form4-03212025_080359.xml 0001415889-25-008771 5316
2025-03-21 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-026516 005-91312 25759826 34 9269
2025-03-20 4 OWNERSHIP DOCUMENT 0001104659-25-026305 15594
2025-03-19 8-K FORM 8-K 1.01,7.01,9.01 0001104659-25-025338 001-39200 25750852 34 9541263 1 1
2025-03-06 S-8 FORM S-8 0001104659-25-021373 333-285596 25715407 33 72316
2025-03-06 10-K 10-K 0001701541-25-000016 001-39200 25715146 34 10218086 1 1
2025-03-06 8-K 8-K 2.02,9.01 0001701541-25-000014 001-39200 25715096 34 230398 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-013934 005-91312 25626923 34 9155
2025-01-31 4 xslF345X05/form4-01312025_090114.xml 0001415889-25-002494 7701
2025-01-31 4 xslF345X05/form4-01312025_090152.xml 0001415889-25-002493 7688
2025-01-31 4 xslF345X05/form4-01312025_090123.xml 0001415889-25-002492 7702
2025-01-31 4 xslF345X05/form4-01312025_090143.xml 0001415889-25-002489 7777
2025-01-31 4 xslF345X05/form4-01312025_090101.xml 0001415889-25-002486 7738
2024-12-16 4 4 0000950170-24-136739 6314
2024-12-16 4 xslF345X05/form4-12162024_091237.xml 0001415889-24-029482 5320
2024-12-16 4 xslF345X05/form4-12162024_091212.xml 0001415889-24-029481 5325
2024-11-14 SC 13G/A bdtx13gasep24.txt 0001897612-24-001981 005-91312 34 6633
2024-11-14 SC 13G BLACK DIAMOND THERAPEUTICS, INC. 0000902664-24-006560 005-91312 241459131 34 67364
2024-11-08 SC 13G us09203e1055_110824.txt 0002012383-24-003406 005-91312 241439572 34 13796
2024-11-05 10-Q 10-Q 0001701541-24-000042 001-39200 241425591 34 5203900 1 1
2024-11-05 8-K 8-K 2.02,9.01 0001701541-24-000040 001-39200 241425585 34 233863 1 1
2024-10-24 SC 13G us09203e1055_102424.txt 0002012383-24-002128 005-91312 241392006 34 13784
2024-10-07 8-K FORM 8-K 5.02,7.01,8.01,9.01 0001104659-24-106676 001-39200 241357998 34 232537 1 1
2024-09-23 8-K FORM 8-K 7.01,8.01,9.01 0001104659-24-101874 001-39200 241314620 34 250742 1 1
2024-09-20 4 4 0000950170-24-108430 6316
2024-09-20 4 xslF345X05/form4-09202024_080939.xml 0001415889-24-023757 5326
2024-09-20 4 xslF345X05/form4-09202024_080904.xml 0001415889-24-023755 5320
2024-08-30 4 4 0000950170-24-102354 15271
2024-08-08 SC 13D/A SC 13D/A 0001193125-24-197045 005-91312 241189260 34 183825
2024-08-06 10-Q 10-Q 0001701541-24-000030 001-39200 241177033 34 4859554 1 1
2024-08-06 8-K 8-K 2.02,9.01 0001701541-24-000028 001-39200 241177013 34 235974 1 1
2024-07-31 144 xsl144X01/primary_doc.xml 0001969223-24-000550 001-39200 241162228 33 18648
2024-07-26 144 xsl144X01/primary_doc.xml 0001969223-24-000532 001-39200 241148253 33 16904
2024-07-16 144 xsl144X01/primary_doc.xml 0001969223-24-000514 001-39200 241120190 33 14552
2024-07-11 144 xsl144X01/primary_doc.xml 0001969223-24-000509 001-39200 241112384 33 13953
2024-07-10 SC 13G/A bdtx13gajun24.txt 0001897612-24-001375 005-91312 34 6624
2024-07-09 144 xsl144X01/primary_doc.xml 0001969223-24-000508 001-39200 241107778 33 12213
2024-06-28 144 xsl144X01/primary_doc.xml 0001969223-24-000504 001-39200 241087153 33 11013
2024-06-27 144 xsl144X01/primary_doc.xml 0001969223-24-000501 001-39200 241080252 33 9839
2024-06-26 144 xsl144X01/primary_doc.xml 0001969223-24-000497 001-39200 241073753 33 9227
2024-06-24 144 xsl144X01/primary_doc.xml 0001969223-24-000495 001-39200 241065234 33 8635
2024-06-21 144 xsl144X01/primary_doc.xml 0001969223-24-000493 001-39200 241061062 33 8040
2024-06-21 4 4 0000950170-24-076273 6311
2024-06-21 4 xslF345X05/form4-06212024_080605.xml 0001415889-24-017843 5315
2024-06-21 4 xslF345X05/form4-06212024_080631.xml 0001415889-24-017842 5321
2024-06-20 144 xsl144X01/primary_doc.xml 0001969223-24-000492 001-39200 241056663 33 7453
2024-06-20 144 xsl144X01/primary_doc.xml 0001969223-24-000491 001-39200 241056662 33 7474
2024-06-18 144 xsl144X01/primary_doc.xml 0001969223-24-000488 001-39200 241051810 33 6273
2024-06-14 144 xsl144X01/primary_doc.xml 0001969223-24-000480 001-39200 241045472 33 5666
2024-06-13 144 xsl144X01/primary_doc.xml 0001969223-24-000471 001-39200 241041348 33 5063
2024-06-12 144 xsl144X01/primary_doc.xml 0001969223-24-000469 001-39200 241038540 33 4473
2024-06-06 4 4 0000950170-24-070044 32977
2024-06-06 4 xslF345X05/form4-06062024_090611.xml 0001415889-24-015828 5656
2024-06-06 4 xslF345X05/form4-06062024_090630.xml 0001415889-24-015826 5671
2024-06-06 4 xslF345X05/form4-06062024_090628.xml 0001415889-24-015823 5670
2024-06-06 4 xslF345X05/form4-06062024_090608.xml 0001415889-24-015821 5676
2024-06-06 4 xslF345X05/form4-06062024_090644.xml 0001415889-24-015819 5606
2024-06-06 8-K FORM 8-K 5.03,5.07,9.01 0001104659-24-069070 001-39200 241025045 34 233745 1 1
2024-05-13 SC 13D/A NEW ENTERPRISE ASSOCIATES 16, L.P. / BLACK DIAMOND THERAPEUTICS, INC. -- SCHEDUL 0001072613-24-000469 005-91312 24940950 34 410504
2024-05-09 SC 13D/A SC 13D/A 0001104659-24-059533 005-91312 24932590 34 78234
2024-05-09 10-Q 10-Q 0001701541-24-000022 001-39200 24928543 34 4555747 1 1
2024-05-09 8-K 8-K 2.02,9.01 0001701541-24-000020 001-39200 24928536 34 224730 1 1
2024-04-24 ARS ARS 0001104659-24-051215 001-39200 24870529 34 18844490
2024-04-24 DEFA14A DEFA14A 0001104659-24-051214 001-39200 24870511 34 747925
2024-04-24 DEF 14A DEF 14A 0001104659-24-051211 001-39200 24870484 34 1331445
2024-04-12 4 xslF345X05/form4-04122024_090409.xml 0001415889-24-010770 5667
2024-04-12 4 xslF345X05/form4-04122024_090430.xml 0001415889-24-010769 5661
2024-04-12 3 xslF345X02/form3-04122024_090449.xml 0001415889-24-010768 11832
2024-04-12 3 xslF345X02/form3-04122024_090412.xml 0001415889-24-010767 11886
2024-04-12 PRE 14A PRE 14A 0001104659-24-046819 001-39200 24842094 34 1351133
2024-04-11 8-K FORM 8-K 5.02,7.01,9.01 0001104659-24-046096 001-39200 24837166 34 228271 1 1
2024-04-03 4 4 0000950170-24-041554 32722
2024-04-03 4 xslF345X05/form4-04042024_120440.xml 0001415889-24-010213 5159
2024-03-12 S-8 S-8 0001104659-24-033254 333-277834 24740250 33 73143
2024-03-12 10-K 10-K 0001701541-24-000011 001-39200 24740182 34 15765260 1 1
2024-03-12 8-K 8-K 2.02,9.01 0001701541-24-000009 001-39200 24740178 34 239829 1 1
2024-03-11 SC 13G/A bdtx13gafeb24.txt 0001897612-24-001356 005-91312 34 6636
2024-02-15 4 xslF345X05/form4-02152024_100235.xml 0001415889-24-003971 5676
2024-02-15 4 xslF345X05/form4-02152024_100242.xml 0001415889-24-003969 5650
2024-02-15 4 xslF345X05/form4-02152024_100227.xml 0001415889-24-003967 5600
2024-02-15 4 xslF345X05/form4-02152024_100219.xml 0001415889-24-003965 5613
2024-02-15 4 xslF345X05/form4-02152024_100218.xml 0001415889-24-003963 5612
2024-02-15 4 xslF345X05/form4-02152024_100202.xml 0001415889-24-003960 5682
2024-02-14 SC 13G bdtx13gdec23.txt 0001897612-24-001273 005-91312 34 6628
2024-02-13 SC 13G/A SC 13G/A 0001193125-24-032778 005-91312 24622453 34 50576
2024-01-18 8-K FORM 8-K 5.02,9.01 0001104659-24-004802 001-39200 24541797 34 200340 1 1
2024-01-04 8-K FORM 8-K 7.01,9.01 0001104659-24-001155 001-39200 24509802 34 21149319 1 1
2023-12-15 4 FORM 4 SUBMISSION 0001209191-23-058790 6471
2023-12-15 4 xslF345X05/form4-12152023_091215.xml 0001415889-23-016532 5082
2023-12-13 8-K FORM 8-K 7.01,8.01,9.01 0001104659-23-125566 001-39200 231482959 34 241339 1 1
2023-11-09 SC 13D/A SC 13D/A 0001193125-23-274632 005-91312 231393882 34 189616
2023-11-06 10-Q 10-Q 0001701541-23-000047 001-39200 231378097 34 4747880 1 1
2023-11-06 8-K 8-K 2.02,9.01 0001701541-23-000045 001-39200 231378095 34 243437 1 1
2023-10-19 4 4 0000950170-23-054142 6264
2023-09-18 4 FORM 4 SUBMISSION 0001209191-23-049791 6472
2023-09-18 4 xslF345X05/form4-09182023_090915.xml 0001415889-23-013339 7600
2023-09-18 4 xslF345X05/form4-09182023_090941.xml 0001415889-23-013337 5083
2023-09-18 8-K FORM 8-K 5.02,7.01,9.01 0001104659-23-101377 001-39200 231260102 34 474639 1 1
2023-08-11 10-Q 10-Q 0001701541-23-000041 001-39200 231161516 34 4662788 1 1
2023-08-11 8-K 8-K 2.02,9.01 0001701541-23-000039 001-39200 231161509 34 245137 1 1
2023-07-07 4 OWNERSHIP DOCUMENT 0001104659-23-079144 13683
2023-07-06 4 FORM 4 SUBMISSION 0001209191-23-041567 6084
2023-07-03 4 4 0000950170-23-031386 6261
2023-06-30 8-K FORM 8-K 1.01,9.01 0001104659-23-077061 001-39200 231061619 34 478105 1 1
2023-06-30 424B5 424B5 0001104659-23-077054 333-268341 231061586 33 633834
2023-06-29 4 FORM 4 SUBMISSION 0000899243-23-016705 6169
2023-06-29 424B5 424B5 0001104659-23-075983 333-268341 231054130 33 634583
2023-06-28 4 xslF345X04/form4-06282023_080616.xml 0001415889-23-010388 9506
2023-06-27 144 xsl144X01/primary_doc.xml 0001973141-23-000110 001-39200 231047150 33 4365
2023-06-27 8-K FORM 8-K 7.01,8.01,9.01 0001104659-23-074995 001-39200 231043973 34 258682 1 1
2023-06-16 4 FORM 4 SUBMISSION 0001209191-23-038084 6467
2023-06-16 4 xslF345X04/form4-06162023_090654.xml 0001415889-23-009960 5078
2023-06-16 4 xslF345X04/form4-06162023_090615.xml 0001415889-23-009959 5242
2023-05-17 4 FORM 4 SUBMISSION 0001209191-23-030458 5498
2023-05-17 4 xslF345X04/form4-05182023_010502.xml 0001415889-23-008248 5551
2023-05-17 4 xslF345X04/form4-05182023_010525.xml 0001415889-23-008247 6987
2023-05-17 4 xslF345X04/form4-05182023_010525.xml 0001415889-23-008246 5594
2023-05-17 4 xslF345X04/form4-05182023_010546.xml 0001415889-23-008245 5588
2023-05-17 4 xslF345X04/form4-05182023_010501.xml 0001415889-23-008243 5573
2023-05-17 4 xslF345X04/form4-05182023_010509.xml 0001415889-23-008242 5430
2023-05-17 4 xslF345X04/form4-05182023_010514.xml 0001415889-23-008241 5523
2023-05-16 8-K FORM 8-K 5.07 0001104659-23-061486 001-39200 23928819 34 210150 1 1
2023-05-09 10-Q 10-Q 0001701541-23-000032 001-39200 23900021 34 4505126 1 1
2023-05-09 8-K 8-K 2.02,9.01 0001701541-23-000030 001-39200 23900017 34 248849 1 1
2023-04-04 ARS ARS 0001104659-23-041625 001-39200 23799451 34 5649069
2023-04-04 DEFA14A DEFA14A 0001104659-23-041623 001-39200 23799420 34 389347
2023-04-04 DEF 14A DEF 14A 0001104659-23-041622 001-39200 23799364 34 2092561
2023-03-20 4 FORM 4 SUBMISSION 0001209191-23-020051 6467
2023-03-20 4 xslF345X04/form4-03202023_080355.xml 0001415889-23-005219 5078
2023-03-20 4 xslF345X04/form4-03202023_080357.xml 0001415889-23-005218 5243
2023-03-09 S-8 FORM S-8 0001104659-23-030569 333-270393 23719653 33 72489
2023-03-09 10-K 10-K 0001701541-23-000020 001-39200 23718223 34 19858282 1 1
2023-03-09 8-K 8-K 2.02,9.01 0001701541-23-000018 001-39200 23718221 34 264888 1 1
2023-02-15 4 OWNERSHIP DOCUMENT 0001104659-23-022391 5512
2023-02-15 4 OWNERSHIP DOCUMENT 0001104659-23-022389 5596
2023-02-15 4 OWNERSHIP DOCUMENT 0001104659-23-022388 7660
2023-02-15 4 OWNERSHIP DOCUMENT 0001104659-23-022387 5570
2023-02-15 4 OWNERSHIP DOCUMENT 0001104659-23-022386 5525
2023-02-15 4 OWNERSHIP DOCUMENT 0001104659-23-022383 5562
2023-02-14 SC 13G/A SC 13G/A 0001193125-23-039140 005-91312 23629429 34 54159
2022-12-23 4 xslF345X03/form4-12232022_091226.xml 0001415889-22-012966 7203
2022-12-19 4 FORM 4 SUBMISSION 0001209191-22-062074 6438
2022-12-19 4 xslF345X03/form4-12202022_021242.xml 0001415889-22-012797 5213
2022-12-19 4 xslF345X03/form4-12202022_021201.xml 0001415889-22-012796 5049
2022-12-19 4 xslF345X03/form4-12202022_021217.xml 0001415889-22-012795 5739
2022-12-19 8-K FORM 8-K 5.02,7.01,9.01 0001104659-22-128050 001-39200 221469660 34 226402 1 1
2022-12-12 8-K FORM 8-K 7.01,8.01,9.01 0001104659-22-126074 001-39200 221456195 34 237346 1 1
2022-11-22 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-11-22 16:01:00 9999999995-22-003381 333-268341 221412162 33 1821
2022-11-18 CORRESP filename1.htm 0001104659-22-120268 7723
2022-11-17 UPLOAD filename1.pdf 0000000000-22-012479 40360
2022-11-14 S-3 S-3 0001193125-22-284590 333-268341 221385562 33 597397
2022-11-08 10-Q 10-Q 0001701541-22-000037 001-39200 221367194 34 5001495 1 1
2022-11-08 8-K 8-K 2.02,9.01 0001701541-22-000034 001-39200 221367188 34 292913 1 1
2022-11-02 4 FORM 4 SUBMISSION 0000899243-22-034751 6454
2022-10-31 4 FORM 4 SUBMISSION 0000899243-22-034543 7978
2022-10-25 4 FORM 4 SUBMISSION 0000899243-22-034121 6446
2022-10-21 4 FORM 4 SUBMISSION 0000899243-22-033945 7976
2022-09-19 4 FORM 4 SUBMISSION 0001209191-22-050622 6439
2022-09-19 4 xslF345X03/form4-09192022_020947.xml 0001415889-22-009774 5049
2022-09-19 4 xslF345X03/form4-09192022_020914.xml 0001415889-22-009773 5214
2022-09-19 4 xslF345X03/form4-09192022_020900.xml 0001415889-22-009771 5279
2022-08-09 10-Q 10-Q 0001701541-22-000029 001-39200 221146411 34 4955787 1 1
2022-08-09 8-K 8-K 2.02,9.01 0001701541-22-000028 001-39200 221146399 34 285281 1 1
2022-07-08 SC 13G us09203e1055_070822.txt 0000834237-22-010344 005-91312 221075092 34 12402
2022-06-30 4/A xslF345X03/form4a-06302022_010603.xml 0001415889-22-007101 5530
2022-06-30 4 xslF345X03/form4-06302022_010621.xml 0001415889-22-007099 5225
2022-06-17 4 FORM 4 SUBMISSION 0001209191-22-037904 6434
2022-06-17 4 xslF345X03/form4-06172022_010656.xml 0001415889-22-006741 5208
2022-06-17 4 xslF345X03/form4-06172022_010651.xml 0001415889-22-006740 5044
2022-06-17 4 xslF345X03/form4-06172022_010601.xml 0001415889-22-006739 5274
2022-06-15 3 xslF345X02/form3-06152022_010626.xml 0001415889-22-006584 12970
2022-06-13 4 xslF345X03/form4-06132022_040616.xml 0001415889-22-006520 5436
2022-06-13 4 FORM 4 SUBMISSION 0001209191-22-036465 5393
2022-06-13 4 xslF345X03/form4-06132022_040655.xml 0001415889-22-006519 5479
2022-06-13 4 OWNERSHIP DOCUMENT 0001104659-22-070650 6934
2022-06-13 4 xslF345X03/form4-06132022_040607.xml 0001415889-22-006518 5544
2022-06-13 4 xslF345X03/form4-06132022_040601.xml 0001415889-22-006517 5408
2022-06-13 4 xslF345X03/form4-06132022_040607.xml 0001415889-22-006516 5473
2022-06-13 4 xslF345X03/form4-06132022_040646.xml 0001415889-22-006515 5458
2022-06-13 4 xslF345X03/form4-06132022_040639.xml 0001415889-22-006514 5315
2022-06-07 8-K FORM 8-K 5.07 0001104659-22-069026 001-39200 221001940 34 208931 1 1
2022-05-11 10-Q 10-Q 0001701541-22-000018 001-39200 22913951 34 4543923 1 1
2022-05-11 8-K 8-K 2.02,9.01 0001701541-22-000017 001-39200 22913868 34 289411 1 1
2022-04-29 4 FORM 4 SUBMISSION 0000899243-22-016006 7974
2022-04-28 DEFA14A DEFA14A 0001104659-22-052258 001-39200 22866765 34 2931419
2022-04-28 DEF 14A DEF 14A 0001104659-22-052245 001-39200 22866706 34 2037862
2022-04-25 8-K FORM 8-K 7.01,9.01 0001104659-22-049317 001-39200 22847508 34 23276198 1 1
2022-04-20 4 FORM 4 SUBMISSION 0000899243-22-015145 7975
2022-04-14 4 FORM 4 SUBMISSION 0000899243-22-014768 7976
2022-04-14 SC 13G/A SC 13G/A 0001193125-22-105204 005-91312 22826516 34 51992
2022-04-13 3 FORM 3 SUBMISSION 0000899243-22-014694 5476
2022-04-07 4 xslF345X03/form4-04072022_010423.xml 0001415889-22-003940 5389
2022-04-07 3 xslF345X02/form3-04072022_010416.xml 0001415889-22-003937 11480
2022-04-07 8-K FORM 8-K 5.02,9.01 0001104659-22-043424 001-39200 22812284 34 227939 1 1
2022-03-18 4 FORM 4 SUBMISSION 0001209191-22-020012 6434
2022-03-18 4 xslF345X03/form4-03182022_040302.xml 0001415889-22-003184 5275
2022-03-18 4 xslF345X03/form4-03182022_040310.xml 0001415889-22-003185 5209
2022-03-17 S-8 FORM S-8 0001104659-22-035067 333-263648 22749510 33 82512
2022-03-17 10-K 10-K 0001701541-22-000007 001-39200 22749098 34 16173076 1 1
2022-03-17 8-K 8-K 2.02,9.01 0001701541-22-000006 001-39200 22749010 34 260475 1 1
2022-02-17 4 xslF345X03/form4-02172022_010257.xml 0001415889-22-001518 5533
2022-02-17 4 xslF345X03/form4-02172022_010237.xml 0001415889-22-001517 5543
2022-02-17 4 xslF345X03/form4-02172022_010228.xml 0001415889-22-001515 7674
2022-02-17 4 xslF345X03/form4-02172022_010238.xml 0001415889-22-001514 5496
2022-02-17 4 xslF345X03/form4-02172022_010232.xml 0001415889-22-001513 5570
2022-02-11 SC 13G/A SC 13G/A 0001193125-22-037291 005-91312 22622276 34 53278
2022-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-22-016649 005-91312 22606597 34 13090
2022-02-04 SC 13G us09203e1055_020422.txt 0000834237-22-007340 005-91312 22593577 34 13364
2022-01-10 8-K FORM 8-K 8.01 0001104659-22-002587 001-39200 22520221 34 198562 1 1
2022-01-10 8-K FORM 8-K 7.01,8.01,9.01 0001104659-22-002475 001-39200 22519645 34 7820145 1 1
2021-12-17 4 FORM 4 SUBMISSION 0001209191-21-070311 6431
2021-12-17 4 xslF345X03/form4-12172021_011225.xml 0001415889-21-006070 5272
2021-11-29 3 xslF345X02/form3-11292021_061117.xml 0001415889-21-005559 18216
2021-11-29 3 xslF345X02/form3-11292021_061138.xml 0001415889-21-005558 15601
2021-11-22 8-K FORM 8-K 5.02 0001104659-21-142198 001-39200 211430128 34 207741 1 1
2021-11-08 10-Q 10-Q 0001701541-21-000039 001-39200 211386509 34 5207462 1 1
2021-11-08 8-K 8-K 2.02,9.01 0001701541-21-000038 001-39200 211386489 34 271639 1 1
2021-09-23 4 FORM 4 SUBMISSION 0001209191-21-057470 6432
2021-09-23 4 xslF345X03/form4-09232021_020923.xml 0001415889-21-004540 5271
2021-09-17 3 xslF345X02/form3-09172021_010945.xml 0001415889-21-004485 19792
2021-08-12 10-Q 10-Q 0001701541-21-000034 001-39200 211165566 34 5169169 1 1
2021-08-12 8-K 8-K 2.02,9.01 0001701541-21-000032 001-39200 211165552 34 255070 1 1
2021-08-11 4 xslF345X03/form4-08112021_010801.xml 0001415889-21-003856 5389
2021-08-11 3 xslF345X02/form3-08112021_010825.xml 0001415889-21-003855 11313
2021-08-10 8-K FORM 8-K 5.02,9.01 0001104659-21-102855 001-39200 211160188 34 39785
2021-08-05 8-K FORM 8-K 5.02 0001104659-21-100444 001-39200 211146364 34 22312
2021-06-22 4 FORM 4 SUBMISSION 0001209191-21-042549 8847
2021-06-22 4 OWNERSHIP DOCUMENT 0001104659-21-084246 6160
2021-06-22 4 OWNERSHIP DOCUMENT 0001104659-21-084245 5500
2021-06-22 4 OWNERSHIP DOCUMENT 0001104659-21-084244 5463
2021-06-22 4 OWNERSHIP DOCUMENT 0001104659-21-084243 5485
2021-06-22 4 OWNERSHIP DOCUMENT 0001104659-21-084242 7678
2021-06-22 4 OWNERSHIP DOCUMENT 0001104659-21-084241 5435
2021-06-22 4 OWNERSHIP DOCUMENT 0001104659-21-084239 5482
2021-06-22 8-K FORM 8-K 5.07 0001104659-21-084116 001-39200 211035328 34 28944
2021-05-21 4 OWNERSHIP DOCUMENT 0001104659-21-070583 8533
2021-05-19 8-K FORM 8-K 7.01,8.01,9.01 0001104659-21-069398 001-39200 21941103 34 65318
2021-05-13 4 OWNERSHIP DOCUMENT 0001104659-21-065995 13241
2021-05-07 10-Q 10-Q 0001701541-21-000025 001-39200 21900236 34 4562571 1 1
2021-05-07 8-K 8-K 2.02,9.01 0001701541-21-000024 001-39200 21900219 34 262846 1 1
2021-05-05 4 FORM 4 SUBMISSION 0000899243-21-018358 9312
2021-04-29 DEFA14A DEFA14A 0001104659-21-057540 001-39200 21870397 34 821378
2021-04-27 DEF 14A DEF 14A 0001104659-21-055586 001-39200 21858920 34 2590480
2021-04-23 4 OWNERSHIP DOCUMENT 0001104659-21-054611 5500
2021-04-23 4 OWNERSHIP DOCUMENT 0001104659-21-054610 5485
2021-04-21 8-K 8-K 5.08 0001193125-21-123584 001-39200 21839556 34 152537 1 1
2021-04-13 4 FORM 4 SUBMISSION 0000899243-21-015666 8801
2021-04-07 4 FORM 4 SUBMISSION 0000899243-21-015309 9313
2021-04-05 4 OWNERSHIP DOCUMENT 0001104659-21-046615 7878
2021-03-25 S-8 S-8 0001193125-21-093400 333-254686 21770122 33 52315
2021-03-25 10-K 10-K 0001701541-21-000018 001-39200 21770104 34 11291137 1 1
2021-03-25 8-K 8-K 2.02,9.01 0001701541-21-000016 001-39200 21770102 34 284788 1 1
2021-03-22 4 FORM 4 SUBMISSION 0001209191-21-022462 6454
2021-03-22 4 FORM 4 SUBMISSION 0000899243-21-012956 9408
2021-03-22 4 FORM 4 SUBMISSION 0000899243-21-012953 5284
2021-03-16 4 FORM 4 SUBMISSION 0000899243-21-011958 9299
2021-03-15 8-K 8-K 8.01 0001193125-21-080409 001-39200 21739678 34 18331
2021-03-04 4 FORM 4 SUBMISSION 0000899243-21-009904 11371
2021-02-19 4 FORM 4 SUBMISSION 0000899243-21-007450 5559
2021-02-19 4 FORM 4 SUBMISSION 0000899243-21-007445 5554
2021-02-19 4 FORM 4 SUBMISSION 0000899243-21-007440 5552
2021-02-19 4 FORM 4 SUBMISSION 0000899243-21-007433 5527
2021-02-19 4 FORM 4 SUBMISSION 0000899243-21-007431 5573
2021-02-12 4 FORM 4 SUBMISSION 0000899243-21-006454 11356
2021-02-11 SC 13G SC 13G 0001193125-21-038641 005-91312 21620599 34 74520
2021-02-10 SC 13G SCHEDULE 13G 0001104659-21-017587 005-91312 21610216 34 13926
2021-02-04 4 FORM 4 SUBMISSION 0000899243-21-004959 8814
2021-02-01 8-K 8-K 1.01 0001193125-21-024781 001-39200 21577938 34 20473
2021-02-01 S-3ASR S-3ASR 0001193125-21-024779 333-252627 21577929 33 1296772
2021-01-22 4 FORM 4 SUBMISSION 0000899243-21-002963 5367
2021-01-22 3 FORM 3 SUBMISSION 0000899243-21-002956 10570
2021-01-20 8-K 8-K 5.02,9.01 0001193125-21-011936 001-39200 21537404 34 40499
2021-01-14 4 FORM 4 SUBMISSION 0000899243-21-002119 22995
2021-01-11 4 FORM 4 SUBMISSION 0000899243-21-001378 9280
2021-01-06 4 FORM 4 SUBMISSION 0000899243-21-000743 11370
2021-01-06 4 FORM 4 SUBMISSION 0000899243-21-000741 15999
2020-12-29 4 FORM 4 SUBMISSION 0000899243-20-035424 7108
2020-12-16 4 FORM 4 SUBMISSION 0000899243-20-034190 5252
2020-12-16 4 FORM 4 SUBMISSION 0000899243-20-034189 7089
2020-12-16 4 FORM 4 SUBMISSION 0000899243-20-034188 9260
2020-12-16 4 FORM 4 SUBMISSION 0000899243-20-034186 11714
2020-12-16 4 FORM 4 SUBMISSION 0000899243-20-034179 24173
2020-12-16 4 FORM 4 SUBMISSION 0000899243-20-034174 19968
2020-12-10 4 FORM 4 SUBMISSION 0000899243-20-033341 11307
2020-12-04 4 FORM 4 SUBMISSION 0000899243-20-032759 9275
2020-12-03 SC 13D/A SC 13D/A 0001193125-20-309605 005-91312 201367437 34 195548
2020-12-03 4 FORM 4 SUBMISSION 0000899243-20-032670 15965
2020-12-01 4 FORM 4 SUBMISSION 0000899243-20-032390 36303
2020-12-01 4 FORM 4 SUBMISSION 0000899243-20-032389 38823
2020-11-25 4 FORM 4 SUBMISSION 0000899243-20-032169 42831
2020-11-25 4 FORM 4 SUBMISSION 0000899243-20-032164 42012
2020-11-23 4 FORM 4 SUBMISSION 0000899243-20-031918 16999
2020-11-23 4 FORM 4 SUBMISSION 0000899243-20-031915 11729
2020-11-23 SC 13D/A SC 13D/A 0001193125-20-299548 005-91312 201333582 34 206616
2020-11-19 4 FORM 4 SUBMISSION 0000899243-20-031772 15764
2020-11-19 4 FORM 4 SUBMISSION 0000899243-20-031771 20913
2020-11-17 4 FORM 4 SUBMISSION 0000899243-20-031322 24829
2020-11-17 4 FORM 4 SUBMISSION 0000899243-20-031320 19801
2020-11-13 4 FORM 4 SUBMISSION 0000899243-20-031061 44114
2020-11-13 4 FORM 4 SUBMISSION 0000899243-20-031060 42020
2020-11-13 4 FORM 4 SUBMISSION 0000899243-20-030997 8776
2020-11-13 4 FORM 4 SUBMISSION 0000899243-20-030996 13379
2020-11-12 4 FORM 4 SUBMISSION 0000899243-20-030855 28750
2020-11-12 4 FORM 4 SUBMISSION 0000899243-20-030854 23844
2020-11-12 4 FORM 4 SUBMISSION 0000899243-20-030831 9247
2020-11-10 4 FORM 4 SUBMISSION 0000899243-20-030745 20914
2020-11-10 4 FORM 4 SUBMISSION 0000899243-20-030744 15765
2020-11-10 10-Q 10-Q 0001701541-20-000032 001-39200 201299614 34 5351917 1 1
2020-11-10 8-K 8-K 2.02,9.01 0001701541-20-000031 001-39200 201299606 34 107262
2020-11-06 4 FORM 4 SUBMISSION 0000899243-20-030583 15766
2020-11-06 4 FORM 4 SUBMISSION 0000899243-20-030580 20915
2020-11-04 4 FORM 4 SUBMISSION 0000899243-20-030419 9274
2020-11-03 4 FORM 4 SUBMISSION 0000899243-20-030313 15467
2020-10-28 4 FORM 4 SUBMISSION 0000899243-20-029546 20912
2020-10-28 4 FORM 4 SUBMISSION 0000899243-20-029541 15764
2020-10-20 4 FORM 4 SUBMISSION 0000899243-20-028811 24830
2020-10-20 4 FORM 4 SUBMISSION 0000899243-20-028802 19803
2020-10-15 4 FORM 4 SUBMISSION 0000899243-20-028373 15768
2020-10-15 4 FORM 4 SUBMISSION 0000899243-20-028366 20916
2020-10-14 4 FORM 4 SUBMISSION 0000899243-20-028186 11319
2020-10-13 4 FORM 4 SUBMISSION 0000899243-20-028072 23839
2020-10-13 4 FORM 4 SUBMISSION 0000899243-20-028070 28745
2020-10-09 4 FORM 4 SUBMISSION 0000899243-20-027904 9247
2020-10-08 4 FORM 4 SUBMISSION 0000899243-20-027853 38072
2020-10-08 4 FORM 4 SUBMISSION 0000899243-20-027852 40434
2020-10-07 4 FORM 4 SUBMISSION 0000899243-20-027717 11330
2020-10-02 4 FORM 4 SUBMISSION 0000899243-20-026891 13905
2020-10-01 4 FORM 4 SUBMISSION 0000899243-20-026660 5176
2020-09-29 4 FORM 4 SUBMISSION 0000899243-20-026445 5468
2020-09-29 3 FORM 3 SUBMISSION 0000899243-20-026443 7662
2020-09-29 8-K 8-K 5.02,9.01 0001193125-20-257227 001-39200 201206186 34 50598
2020-09-25 SC 13D/A SC 13D/A 0001193125-20-254645 005-91312 201200595 34 190917
2020-09-21 4 FORM 4 SUBMISSION 0000899243-20-025830 42150
2020-09-21 4 FORM 4 SUBMISSION 0000899243-20-025816 42973
2020-09-16 4 FORM 4 SUBMISSION 0000899243-20-025361 13379
2020-09-16 4 FORM 4 SUBMISSION 0000899243-20-025360 8749
2020-09-10 4 FORM 4 SUBMISSION 0000899243-20-024836 7678
2020-09-10 3 FORM 3 SUBMISSION 0000899243-20-024834 7645

Latest XBRL company facts

One latest value per concept from companyfacts (246 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 57.47M 2026-11-05 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
dei EntityPublicFloat Entity Public Float USD 113.75M 2025-06-30 2025 FY 10-K 2026-03-16 0001701541-26-000009
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 1.43M 2025-01-01 2025-12-31 DEF 14A 2026-04-29 0001104659-26-051474
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 1.32M 2025-01-01 2025-12-31 DEF 14A 2026-04-29 0001104659-26-051474
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 2.57M 2025-01-01 2025-12-31 DEF 14A 2026-04-29 0001104659-26-051474
ecd PeoTotalCompAmt PeoTotalCompAmt USD 2.23M 2025-01-01 2025-12-31 DEF 14A 2026-04-29 0001104659-26-051474
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 89 2025-01-01 2025-12-31 DEF 14A 2026-04-29 0001104659-26-051474
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 1.04M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 14.36M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 843,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 1.31M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -309,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 582.07M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Decrease for Tax Withholding Obligation USD 185,000 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 2.23M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 16,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-17 0001701541-22-000007
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 5.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 11.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 7.35M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap Assets Assets USD 115.56M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap AssetsCurrent Assets, Current USD 106.54M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 100.95M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 4,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 313,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 87.25M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost USD 140.09M 2020-06-30 2020 Q2 10-Q 2020-08-11 0001701541-20-000024
us-gaap AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value USD 140.50M 2020-06-30 2020 Q2 10-Q 2020-08-11 0001701541-20-000024
us-gaap AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost USD 139.92M 2020-06-30 2020 Q2 10-Q 2020-08-11 0001701541-20-000024
us-gaap AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value USD 140.52M 2020-06-30 2020 Q2 10-Q 2020-08-11 0001701541-20-000024
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 86.95M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 86.95M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap AvailableForSaleSecuritiesDebtSecuritiesNoncurrent Debt Securities, Available-for-sale, Noncurrent USD 140.52M 2020-06-30 2020 Q2 10-Q 2020-08-11 0001701541-20-000024
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 34,000 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-11 0001701541-23-000041
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 15.08M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 15.92M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -5.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap CommitmentsAndContingencies Commitments and Contingencies USD 0 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 24.03M 2019-12-31 2019 FY 10-K 2020-03-24 0001701541-20-000009
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 500.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 57.47M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 57.47M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap CommonStockValue Common Stock, Value, Issued USD 8,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -29.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-17 0001701541-22-000007
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously Recorded USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 44.59M 2022-09-30 2022 Q3 10-Q 2022-11-08 0001701541-22-000037
us-gaap DebtSecuritiesAvailableForSaleRealizedGainLoss Debt Securities, Available-for-sale, Realized Gain (Loss) USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0001701541-23-000020
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 0 2020-12-31 2020 FY 10-K 2021-03-25 0001701541-21-000018
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 126.69M 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 17.50M 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 2.47M 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 81.36M 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 39,000 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 14.61M 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 7.29M 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap DeferredTaxAssetsTaxDeferredExpenseOther Deferred Tax Assets, Tax Deferred Expense, Other USD 0 2019-12-31 2019 FY 10-K 2020-03-24 0001701541-20-000009
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other USD 744,000 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 124.22M 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 2.47M 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 0 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 287,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay pure 0.06 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap Depreciation Depreciation USD 83,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 0 2020-12-31 2020 FY 10-K 2021-03-25 0001701541-21-000018
us-gaap DividendsCommonStockCash Dividends, Common Stock, Cash USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-24 0001701541-20-000009
us-gaap DividendsPreferredStockCash Dividends, Preferred Stock, Cash USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-24 0001701541-20-000009
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 0 2020-12-31 2020 FY 10-K 2021-03-25 0001701541-21-000018
us-gaap DueToRelatedPartiesCurrentAndNoncurrent Due to Related Parties USD 0 2021-12-31 2021 FY 10-K 2022-03-17 0001701541-22-000007
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.5 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -2.05 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001701541-21-000018
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.5 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.246 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure 0.092 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.056 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 2.32M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 8.56M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 USD 16,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001701541-21-000018
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings USD 6.39M 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-25 0001701541-21-000018
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances USD 10.40M 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-25 0001701541-21-000018
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements USD 10.40M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-24 0001701541-20-000009
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 0 2020-12-31 2020 FY 10-K 2021-03-25 0001701541-21-000018
us-gaap GainLossOnDispositionOfIntangibleAssets Gain (Loss) on Disposition of Intangible Assets USD 2.23M 2022-01-01 2022-12-31 2024 Q1 10-Q 2024-05-09 0001701541-24-000022
us-gaap GainLossOnSaleOfInvestments Gain (Loss) on Sale of Investments USD 56,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -37,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-09 0001701541-23-000032
us-gaap GainLossOnTerminationOfLease Gain (Loss) on Termination of Lease USD 5,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-09 0001701541-23-000020
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 14.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap IncomeLossAttributableToParent Income (Loss) Attributable to Parent, before Tax USD 22.36M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD 22.36M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0001701541-24-000011
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -5.57M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD 4.75M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 9,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 2.07M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 4,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 1.27M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap IncreaseDecreaseInAccountsPayableTrade Increase (Decrease) in Accounts Payable, Trade USD 462,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD -788,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap IncreaseDecreaseInDueToRelatedPartiesCurrent Increase (Decrease) in Due to Related Parties, Current USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-08 0001701541-21-000039
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 176,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 421,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 670,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-06 0001701541-25-000039
us-gaap InterestExpense Interest Expense USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-17 0001701541-22-000007
us-gaap InvestmentIncomeAmortizationOfDiscount Investment Income, Amortization of Discount USD 990,000 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-10 0001701541-20-000032
us-gaap InvestmentIncomeAmortizationOfPremium Investment Income, Amortization of Premium USD 536,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0001701541-23-000020
us-gaap InvestmentIncomeNetAmortizationOfDiscountAndPremium Investment Income, Net, Amortization of Discount and Premium USD 535,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap InvestmentIncomeNonoperating Investment Income, Nonoperating USD 2.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap LeaseCost Lease, Cost USD -82,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 21.57M 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 3.89M 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 4.60M 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 2.25M 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 2.18M 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 3.93M 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 4.72M 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 1.11M 2024-09-30 2024 Q3 10-Q 2024-11-05 0001701541-24-000042
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 2.79M 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap Liabilities Liabilities USD 27.48M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 115.56M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap LiabilitiesCurrent Liabilities, Current USD 15.40M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap LineOfCreditAssumed1 Line of Credit Assumed USD 1.17M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-10 0001701541-20-000032
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 44,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 20.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -26.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -28.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap NoncashOrPartNoncashAcquisitionInvestmentsAcquired1 Noncash or Part Noncash Acquisition, Investments Acquired USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0001701541-24-000011
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 6.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap OperatingExpenses Operating Expenses USD 35.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -35.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap OperatingLeaseCost Operating Lease, Cost USD 2.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 5.28M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 18.78M 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 3.96M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 12.08M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap OperatingLeasePayments Operating Lease, Payments USD 3.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 7.65M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 528,000 2019-12-31 2020 FY 10-K 2021-03-25 0001701541-21-000018
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 223,000 2019-12-31 2020 FY 10-K 2021-03-25 0001701541-21-000018
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 0 2019-12-31 2020 FY 10-K 2021-03-25 0001701541-21-000018
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 77,000 2019-12-31 2020 FY 10-K 2021-03-25 0001701541-21-000018
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 228,000 2019-12-31 2020 FY 10-K 2021-03-25 0001701541-21-000018
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 415,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-25 0001701541-21-000018
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.053 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 249,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, after Tax USD -410,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-24 0001701541-20-000009
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0001701541-23-000020
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 3.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale USD 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-08 0001701541-22-000037
us-gaap PaymentsForRestructuring Payments for Restructuring USD 1.80M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0001701541-25-000016
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001701541-21-000018
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 1.27M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-17 0001701541-22-000007
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 40.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0001701541-25-000016
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 4.51M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-17 0001701541-22-000007
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001701541-21-000018
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised USD 32,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-12 0001701541-25-000022
us-gaap ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale USD 61.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 177,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0001701541-23-000020
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 1.59M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 282,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap ReclassificationsOfTemporaryToPermanentEquity Reclassifications of Temporary to Permanent Equity USD 200.57M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001701541-21-000018
us-gaap RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty Related Party Transaction, Expenses from Transactions with Related Party USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-17 0001701541-22-000007
us-gaap RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001701541-21-000018
us-gaap ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff Research and Development Asset Acquired Other than Through Business Combination, Written-off USD 710,000 2022-01-01 2022-12-31 2024 Q1 10-Q 2024-05-09 0001701541-24-000022
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 21.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 1.17M 2022-12-31 2022 FY 10-K 2023-03-09 0001701541-23-000020
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 835,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap RestructuringCharges Restructuring Charges USD 2.94M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0001701541-25-000016
us-gaap RestructuringReserve Restructuring Reserve USD 1.15M 2024-12-31 2024 FY 10-K 2025-03-06 0001701541-25-000016
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -493.69M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001701541-21-000018
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 109,000 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-09 0001701541-22-000029
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 5.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price USD/shares 3.2 2019-06-30 2020 FY 10-K 2021-03-25 0001701541-21-000018
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.972 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.043 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 97,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 7.35M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 6.6 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 82,348 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 1.04M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-08 0001701541-22-000037
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 16.16 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-08 0001701541-22-000037
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 138,694 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 2.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 2 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 149,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 11.70M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 5.23 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 149,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 11.70M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 5.23 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 6.13M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 1.7 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 4.29 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 3.02 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 2.48 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 88.08M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 3.016 2020-01-21 2021 FY 10-K 2022-03-17 0001701541-22-000007
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 127,707 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 200.57M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-17 0001701541-22-000007
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 12,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 24.49M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 0 2019-01-01 2019-03-31 2020 Q3 10-Q 2020-11-10 0001701541-20-000032
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 0 2020-07-01 2020-09-30 2020 Q3 10-Q 2020-11-10 0001701541-20-000032
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 217,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap SubleaseIncome Sublease Income USD 3.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 0 2020-12-31 2020 FY 10-K 2021-03-25 0001701541-21-000018
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 194.73M 2019-12-31 2020 FY 10-K 2021-03-25 0001701541-21-000018
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0 2019-12-31 2020 FY 10-K 2021-03-25 0001701541-21-000018
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 64.87M 2019-12-31 2020 FY 10-K 2021-03-25 0001701541-21-000018
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 64.84M 2019-12-31 2020 FY 10-K 2021-03-25 0001701541-21-000018
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2020-12-31 2020 FY 10-K 2021-03-25 0001701541-21-000018
us-gaap UndistributedEarningsOfForeignSubsidiaries Undistributed Earnings of Foreign Subsidiaries USD 0 2023-12-31 2023 FY 10-K 2024-03-12 0001701541-24-000011
us-gaap UnrealizedGainLossOnDerivatives Unrealized Gain (Loss) on Derivatives USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001701541-21-000018
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD -3.36M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001701541-26-000009
us-gaap VariableLeaseCost Variable Lease, Cost USD 711,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 57.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 32.91M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001701541-21-000018
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 57.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001701541-26-000032

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →